A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects
Clinical trial NCT07500181 · RECRUITING
Trial details
- NCT number
- NCT07500181
- Sponsor
- Basilea Pharmaceutica
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-04
- Primary completion
- 2027-06-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.